Goserelin can help preserve the fertility of young women who are undergoing chemotherapy for certain types of breast cancer, a new study reveals.
The cancer drug also appeared to improve survival, according to the results of a phase III clinical trial unveiled at the American Society for Clinical Oncology annual meeting.
Breast Cancer Screening using Mammogram
Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.
Advertisement
Early menopause can be triggered by breast cancer chemotherapy. Some women resume menstruating after chemo and can have children, but many cannot.
"I think these findings are going to change our clinical practice," said senior study author Kathy Albain of Loyola University Medical Center.
Some 49,000 women under 50 are diagnosed with breast cancer each year in the United States, making up about a quarter of all breast cancer cases.
![Breast Cancer - Prevention and Management with Lifestyle Changes]( "Breast Cancer - Prevention and Management with Lifestyle Changes")
Lifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity.
About 15 percent of young women have cancers that are hormone receptor negative, and these are the women who could benefit from taking goserelin to essentially put the ovaries at rest during chemo, researchers said.
The study randomly assigned 131 patients to receive standard chemotherapy and 126 to receive chemotherapy plus goserelin by injection once every four weeks.
Nearly half (45 percent) of the women on standard chemo stopped menstruating after two years.
Only 20 percent of the women receiving goserelin had stopped menstruating.
Pregnancies were twice as common in the goserelin group -- 21 percent compared to 11 percent.
And 89 percent of the women taking goserelin had no signs or symptoms of cancer four years later, compared to 78 percent of those receiving standard chemotherapy.
Survival was higher too -- 92 percent in the goserelin group and 82 percent in the standard chemo group.
Albain said women who need to undergo chemo for early breast cancer should consider taking goserelin to prevent premature ovarian failure.
Goserelin, known by the brand name Zoladex, was approved by the Food and Drug Administration for prostate cancer, certain benign gynecological disorders and certain breast cancers.
Source: AFP
Some 49,000 women under 50 are diagnosed with breast cancer each year in the United States, making up about a quarter of all breast cancer cases.
Breast Cancer - Prevention and Management with Lifestyle Changes
Lifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity.
Advertisement
About 15 percent of young women have cancers that are hormone receptor negative, and these are the women who could benefit from taking goserelin to essentially put the ovaries at rest during chemo, researchers said.
The study randomly assigned 131 patients to receive standard chemotherapy and 126 to receive chemotherapy plus goserelin by injection once every four weeks.
Nearly half (45 percent) of the women on standard chemo stopped menstruating after two years.
Only 20 percent of the women receiving goserelin had stopped menstruating.
Pregnancies were twice as common in the goserelin group -- 21 percent compared to 11 percent.
And 89 percent of the women taking goserelin had no signs or symptoms of cancer four years later, compared to 78 percent of those receiving standard chemotherapy.
Survival was higher too -- 92 percent in the goserelin group and 82 percent in the standard chemo group.
Albain said women who need to undergo chemo for early breast cancer should consider taking goserelin to prevent premature ovarian failure.
Goserelin, known by the brand name Zoladex, was approved by the Food and Drug Administration for prostate cancer, certain benign gynecological disorders and certain breast cancers.
Source: AFP
Breast Cancer Management: Advances
The crab that invades the breast is no more a fear factor with all the advancements that medical science and customized protocols can fight breast cancer. the recent developments in the management of breast cancer.
Advertisement
 Breast Cancer during PregnancyManagement of breast cancer during pregnancy or pregnancy associated breast cancer requires special consideration to avoid harm to the fetus. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
Lipid nanoparticles use M13, a potent anti-ulcerative colitis compound, in an oral formulation to combat colitis-linked cancer.
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
